Essential Tips for Enrolling Rare Disease Trials
The last decade has seen an explosion in clinical trials for therapies focused on rare diseases. PhRMA reports that there are more than 800 orphan drugs currently in development or regulatory review.… Read More
DIA 2019: Connections, Selfies, and Bridging the Gap
The Imperial Clinical Research Services business development team recently attended the Drug Information Association (DIA) Global Annual Meeting in San Diego. The DIA Annual Meeting gathers stakeholders across the drug development industry… Read More
Bridging the Gaps in Study Conduct
Today’s Challenges There are some amazing things happening in the field of clinical research right now. The hottest topics at the conferences I’ve attended over the past 18 months have been those… Read More
Tackling A Clinical Research Challenge Head-On at the 2019 Bridging Clinical Research & Clinical Health Care Conference
For the second year in a row, clinical research executives gathered in the nation’s capital to discuss one of the biggest challenges tormenting the industry – how to improve the number of… Read More
Tech Buzzes and Execution Beckons at SCOPE 2019
The Summit for Clinical Ops Executives, or SCOPE as most know it, returned to Orlando this year. Held at the Hyatt Regency Orlando, on the famed but increasingly overcrowded International Drive, the… Read More
Report from Montreal: Operational Excellence in Clinical Trials Summit
At the Operational Excellence in Clinical Trials Summit meeting in Montreal in September, I had the privilege to serve as keynote speaker and a panelist for several discussions. The conference brought together… Read More
Bridging Research and Health Care: If We Don’t Do it, Someone Else Will
I recently had the honor and privilege of representing Imperial at the inaugural Bridging Clinical Research and Clinical Health Care conference in National Harbor, Maryland. It was interesting and worthwhile. The conference… Read More
3 Ways to Outsmart the Big Dogs as You Move into the Clinic
You’ve done all the background work. You’ve navigated the complex U.S. regulatory environment and achieved investigational new drug approval. You’ve secured investors and assembled your core team. You are now preparing for… Read More
The Role of Patient Engagement in the Transition from Lab to Clinic
The drug discovery and development process is a complex and challenging landscape, especially for the majority of small biopharmaceutical and medical device companies. It’s truly a survival of the fittest environment, fraught… Read More
Do We Have a Performance Measurement Problem in Patient Recruitment?
It’s fairly well accepted in today’s clinical research environment that proactive strategies for driving enrollment in clinical trials are part of the complicated equation of success. According to a 2016 survey of… Read More
